Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy source : Www.globenewswire.com save search
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
LXEO | $11.88 -3.1% 14K
|
|
| O: 5.32%
H: 0.0%
C: -2.63%
lx2006 fda candidate granted treatment designation for therapeutics therapy
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
ITCI 1 d | $72.28 -5.75% 3.1M
|
Health Technology
|
| O: 14.75%
H: 12.75%
C: 6.04%
positive topline therapy results study
Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-15 (Crawled : 14:00) - globenewswire.com
IMMX | $2.31 -7.6% 110K
|
|
| O: 1.09%
H: 1.79%
C: -4.66%
nxc-201 presentation cell biopharma for meeting therapy
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
CRBU | $3.93 0.51% 780K
|
Health Technology
|
| O: -0.71%
H: 5.27%
C: -2.4%
presentation cell meeting therapy
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
Published: 2024-04-10 (Crawled : 16:00) - globenewswire.com
ORGS | $0.5089 13K
|
Health Technology
|
| O: 7.22%
H: 69.23%
C: 0.73%
partnership cell global therapy
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.385 -3.82% 2.9M
|
Health Technology
|
| O: 2.92%
H: 3.41%
C: 2.27%
ocu400 approval positive for therapy
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
Published: 2024-04-09 (Crawled : 21:00) - globenewswire.com
INAB | $1.0 48K
|
|
| O: 6.42%
H: 1.72%
C: -5.17%
cell preclinical for therapy platform
Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health
Published: 2024-04-09 (Crawled : 13:00) - globenewswire.com
NUWE | $0.2732 -1.66% 130K
|
Manufacturing
|
| O: 3.84%
H: 0.0%
C: -3.05%
smartflow aquadex health system ford therapy
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-08 (Crawled : 20:00) - globenewswire.com
IPSC | $2.965 4.4% 78K
|
Professional, Scientific, and T...
|
| O: -1.59%
H: 8.87%
C: 7.8%
association cancer cell research preclinical for meeting technology therapeutics therapy platform
Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
TOVX | $0.447 2.76% 4.6K
|
Manufacturing
|
| O: 0.62%
H: 2.02%
C: -1.11%
presentation cell for meeting therapy
Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.385 -3.82% 2.9M
|
Health Technology
|
| O: 26.42%
H: 3.48%
C: -6.47%
ocu400 fda first clearance trial therapy
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published: 2024-04-06 (Crawled : 20:20) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $92.61 -0.51% 430K
|
Health Technology
| Email alert
Add to watchlist
leqvio novartis therapy show
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
Published: 2024-04-04 (Crawled : 15:30) - globenewswire.com
SNN | $24.16 1.0% 400K
|
Health Technology
|
| O: -0.12%
H: 0.1%
C: -0.98%
institute health care system therapy negative
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
CRSP M | $56.73 2.11% 660K
|
Health Technology
|
| O: -2.41%
H: 0.23%
C: -0.03%
crispr cell meeting therapeutics therapy
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
SNN | $24.16 1.0% 400K
|
Health Technology
|
| O: -3.19%
H: 0.04%
C: -1.25%
care system therapy living negative
Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
SLDB | $9.46 -5.31% 36K
|
Health Technology
|
| O: -9.02%
H: 0.0%
C: -7.65%
sgt-003 fda rare candidate disease designation duchenne therapy
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
MBIO | $0.4 4.17% 140K
|
Health Technology
|
| O: 7.14%
H: 1.9%
C: -0.95%
FBIO | $1.81 2.26% 250K
|
Health Technology
|
| O: -0.46%
H: 0.46%
C: -7.41%
t-cell expansion vision therapy platform
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
Published: 2024-03-25 (Crawled : 12:30) - globenewswire.com
STIM | $3.835 -3.16% 25K
|
Health Technology
|
| O: 13.48%
H: 3.96%
C: -1.88%
neurostar fda depression treatment clearance advanced therapy
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Published: 2024-03-22 (Crawled : 17:00) - globenewswire.com
MRKR | $4.31 3.4K
|
Consumer Services
|
| O: 2.06%
H: 3.68%
C: 3.68%
conference cell therapeutics therapy
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
children approved therapeutics therapy
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.